Ansagan, Almera .

HRN: 27-54-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2025
CEFUROXIME 500MG (TAB)
08/01/2025
08/08/2025
PO
500mg
BID
Thinly Msaf
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: